Metabolism of Piromidic Acid, a New Antibacterial Agent. III. Determination of Piromidic Acid and Its Metabolites in Blood, Urine and Bile of Rats and Humans
スポンサーリンク
概要
- 論文の詳細を見る
The chemical determinations of piromidic acid (PA, 5,8-dihydro-8-ethyl-5-oxo-2-pyrrolidinopyrido [2,3-d] pyrimidine-6-carboxylic acid=pyrrolidino-PPA) and its metabolites in blood, urine and bile of rats receiving a single oral (100mg/kg) or intravenous (25mg/kg) dose of PA were performed utilizing thin-layer chromatographic separation, followed by ultraviolet spectroscopic determination. The same determinations were also made for human subjects receiving oral PA of 1 g. The following results were obtained : (1) PA was rapidly metabolized to M-II (2-hydroxypyrrolidino-PPA) and M-V (3-hydroxypyrrolidino-PPA) in both species after oral and intravenous administrations. (2) Blood levels of M-II, M-IV (3-hydroxycarbonylpropylamino-PPA), unchanged PA and M-V in order of decreasing amounts in rats all reached their peaks 2 to 3 hr after oral administration. On the contrary, blood levels of M-III (amino-PPA) were too low to be determined. Analogous results were also obtained in humans. (3) An average 24-hr biliary excretion in rats receiving intravenous PA was about 63% of the dose and a major metabolite was M-IV, accounting for about 23% of the dose. (4) In man, an average recovery in 24-hr urine was about 42% of the dose after oral administration. M-IV, M-V, M-II, M-III, PA and glucuronides were excreted in order of decreasing amount. In rats, the similar results were obtained after oral and intravenous administrations. (5) The antibacterial activity in blood, bile and urine was found to be associated almost entirely with M-II, M-V, and unchanged PA in both species after oral or intravenous administration, with significant predominance of M-V in the urine. Urinary or biliary levels of total active materials were found to be high enough to inhibit Escherichia coli.
- 公益社団法人日本薬学会の論文
- 1976-07-25
著者
-
橋本 昌久
大日本製薬株式会社総合研究所
-
橋本 昌久
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
中村 清
Research And Development Division Dainippon Pharmaceutical Co. Ltd.
-
橋本 昌久
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
関根 豊
Research and Development Division, Dainippon Pharmaceutical Co., Ltd.
-
宮本 美枝
Research and Development Division, Dainippon Pharmaceutical Co., Ltd.
-
関根 豊
Department of Drug Metabolism, Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
関根 豊
Department Of Drug Metabolism Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
宮本 美枝
Research And Development Division Dainippon Pharmaceutical Co. Ltd.
関連論文
- マウスおよびラットにおけるLoperamide Hydrochlorideの身体依存性
- Binding of Sulfonamides to Erythrocyte Proteins and Possible Drug-Drug Interaction
- The Synthesis of 2-and 4-Alkoxymethylestrogens.
- Binding of Sulfonamides to Erythrocytes and Their Components
- Autoradiographic Evidences on the Perilobular Distribution of Dehydrocorydaline-^C in the Mouse Liver
- Studies on the Metabolism of Sulfadiazine. I. On the Separation and Identification of Excrements in Human Urine after its Oral Administration.
- リスザルの14C-ヒポキサンチン代謝に対するアロプリノ-ルの影響についてのオ-トラジオグラフィ的研究〔英文〕
- モルモット聴器における14C-pipemidic acidの分布
- Antianoxic Effect of Meclofenoxate related to Its Disposition
- Comparative Studies on the Metabolism of β-Dimethylaminoethanol in the Mouse Brain and Liver Following Administration of β-Dimethyl-aminoethanol and Its p-Chlorophenoxyacetate, Meclofenoxate
- Uptake by Brain and Distribution of Radioactivity after Intravenous Administration of ^C-Labelled Meclofenoxate in Mice
- Metabolism of Piromidic Acid, a New Antibacterial Agent. V. Pharmacokinetics of Piromidic Acid in Humans
- Metabolism of Piromidic Acid, a New Antibacterial Agent. IV. Pharmacokinetics of Piromidic Acid in Rats
- Metabolism of Piromidic Acid, a New Antibacterial Agent. III. Determination of Piromidic Acid and Its Metabolites in Blood, Urine and Bile of Rats and Humans
- Metabolism of Piromidic Acid, a New Antibacterial Agent. II. In Vitro Metabolic Pathway of Piromidic Acid in Rats
- A New Route to 2-Methyl-19-norsteroids
- Intestinal Absorption of a β-Adrenergic Blocking Agent Nadolol. III. : Nuclear Magnetic Resonance Spectroscopic Study on Nadolol-Sodium Cholate Micellar Complex and Intestinal Absorption of Nadolol Derivatives in Rats
- Intestinal Absorption of a β-Adrenergic Blocking Agent Nadolol. II. : Mechanism of the Inhibitory Effect on the Intestinal Absorption of Nadolol by Sodium Cholate in Rats
- Intestinal Absorption of β-Adrenergic Blocking Agent Nadolol. I. : Comparison of Absorption Behaivor of Nadolol with Those of Other β-Blocking Agents in Rats
- Studies on the Metabolism of Sulfadiazine. II. Quantitative Separation of Excrements in the Human Urine after Administration of Sulfadiazine
- ウナギにおけるピロミド酸および代謝物の組織内濃度
- A New Method for Human Serum Phenytoin Based on Enzyme Immunoassay
- A Method for the Determination of Human Serum Phenobarbital Based on a Competitive Binding Enzyme-Immunoassay